Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Fairbairn Malcolm, Director. Director active across 1 company, notably TFF Pharmaceuticals, Inc.. Cumulatively, 2 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €147k. History available since 19 May 2021. The latest transaction was filed on 19 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Malcolm Fairbairn is a Director at TFF Pharmaceuticals, Inc. He plays a key role on the board, bringing his experience and skills to influence the company's strategic decisions. His involvement is crucial for the development of TFF Pharmaceuticals, Inc.